GCM
AGN

Gables Capital Management’s Allergan plc AGN Stock Holding History

Gables Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-165
Closed -$29K – 429
2020
Q1 		$29K Buy
+165
New +$31.1K 0.02% 230
2018
Q3 		– Sell
-20
Closed -$3K – 393
2018
Q2 		$3K Buy
+20
New +$3.21K ﹤0.01% 356

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Gables Capital Management's AGN Position: Q2 2020 in Review

Gables Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 165 shares — an estimated $29K sold.

Gables Capital Management first reported a position in AGN in Q2 2018 and held it in 2 quarters. The position peaked at $29K in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Gables Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Gables Capital Management sold 165 Allergan plc shares in Q2 2020, an estimated $29K.
  • Gables Capital Management first reported a position in Allergan plc in Q2 2018 and held it in 2 quarters.
  • Gables Capital Management's Allergan plc position peaked at $29K in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Gables Capital Management's 13F filing for Q2 2020, filed 30 Jul 2020.